Picture of BioInvent International AB logo

BINV BioInvent International AB Balance Sheet

0.000.00%
se flag iconLast trade - 00:00
HealthcareAdventurousSmall CapMomentum Trap

Annual balance sheet for BioInvent International AB, fiscal year end - December 31st, SEK millions except per share, conversion factor applied.

R2017
December 31st
2018
December 31st
2019
December 31st
2020
December 31st
2021
December 31st
Period Length:
Source:Interim ReportARSARSARSARS
Standards:
IFRS
IFRS
IFRS
IFRS
IFRS
Status:FinalFinalFinalFinalFinal
Cash
Short Term Investments
Cash and Short Term Investments13468.91547291,083
Net Total Accounts Receivable
Net Total Receivables14.723.929.935.59.39
Total Inventory
Prepaid Expenses
Total Current Assets1511021937731,116
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment183329.649.1
Net Intangible Assets
Long Term Investments
Other Long Term Assets
Total Assets1711202268031,447
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities40.532.847.253.558.8
Capital Lease Obligations
Total Long Term Debt
Total Debt
Total Liabilities40.532.856.759.180.3
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity13087.61697431,367
Total Liabilities & Shareholders' Equity1711202268031,447
Total Common Shares Outstanding

Or unlock with your email

Or unlock with your email